<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04178434</url>
  </required_header>
  <id_info>
    <org_study_id>20191111</org_study_id>
    <nct_id>NCT04178434</nct_id>
  </id_info>
  <brief_title>Internat-based Treatment of Stress and Anxiety in Myocardial Infarction With Non-obstructive Coronary Arteries</brief_title>
  <acronym>e-SMINC</acronym>
  <official_title>E-health Treatment of Stress and Anxiety in Stockholm Myocardial Infarction With Non-obstructive Coronaries Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Per Tornvall</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mid Sweden University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo&#xD;
      syndrome often have high levels of stress and anxiety. At present there are no treatment&#xD;
      alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT),&#xD;
      primarily aiming at relieving stress, has been shown to decrease morbidity in patient with&#xD;
      myocardial infarction with obstructive coronary arteries. The present open randomized study&#xD;
      aims to decrease stress and anxiety in patients with myocardial infarction with&#xD;
      non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on&#xD;
      stress and anxiety.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)</measure>
    <time_frame>12-14 weeks after the acute event</time_frame>
    <description>Normalisation of PSS-14 (&lt;25 on a scale 0-56 with high numbers indicating increased stress)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>12-14 weeks after the acute event</time_frame>
    <description>Normalisation of HADS-A (&lt;8 on a scale 0-21 with high numbers indicating increased anxiety)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>PSS-14 (&lt;25 on a scale 0-56 with high numbers indicating increased stress)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>HADS-A (&lt;8 on a scale 0-21 with high numbers indicating increased anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rated quality-of-life determined by Research ANd Development-36 (RAND-36)</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>RAND-36: 0-100 with high numbers indicating better quality-of-life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rated cardiac anxiety determined by Cardiac Anxiety Questionnaire (CAQ)</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>CAQ: 0-72 with high numbers indicating increased cardiac anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rated post-traumatic symptoms determined by Impact of Event Scale-6 (IES-6)</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>IES-6: 0-30 with high numbers indicating increased post-traumatic symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sick leave</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>Self-reported total number of days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-care visits</measure>
    <time_frame>10, 20 and 50 weeks after randomisation</time_frame>
    <description>Self-reported total number of visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol in hair</measure>
    <time_frame>10 weeks after randomisation</time_frame>
    <description>Hair cortisol will be determined by RIA-technique in pg/mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological recovery after stress determined by Heart Rate Variability (HRV)</measure>
    <time_frame>10 weeks after randomisation</time_frame>
    <description>HRV will be measured by time and frequency domains and by non-linear methods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physiological recovery after stress determined by salivary cortisol</measure>
    <time_frame>10 weeks after randomisation</time_frame>
    <description>Salivary cortisol will be determined by RIA-technique in pg/mg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Internet-based CBT intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A nine step internet-based intervention with focus on stress and anxiety</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Regular follow-up with two doctor and one nurse appointment</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based CBT intervention</intervention_name>
    <description>A nine step intervention including internet-based feedback by psychologists</description>
    <arm_group_label>Internet-based CBT intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography&#xD;
             without diameter stenosis ≥50%&#xD;
&#xD;
          -  age 35-80 years&#xD;
&#xD;
          -  admission-ECG with sinus rhythm&#xD;
&#xD;
          -  PSS-14 ≥ 25 and/or HADS-A ≥ 8 during admission&#xD;
&#xD;
          -  reading and writing proficiency in Swedish&#xD;
&#xD;
          -  computer/Internet access and literacy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  strong clinical suspicion of myocarditis&#xD;
&#xD;
          -  spontaneous coronary artery dissection&#xD;
&#xD;
          -  acute pulmonary embolism&#xD;
&#xD;
          -  acute myocardial infarction type 2&#xD;
&#xD;
          -  cardiomyopathy other than takotsubo syndrome&#xD;
&#xD;
          -  a previous myocardial infarction due to CAD&#xD;
&#xD;
          -  expected poor compliance to behavioural therapy&#xD;
&#xD;
          -  not likely to survive &gt; one year due to for example cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 11, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Per Tornvall</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Non-obstructive coronary arteries</keyword>
  <keyword>Takotsubo syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT04178434/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

